Pacira BioSciences PCRX
NASDAQ PCRX
$25.05 -0.60 (-2.34%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Total Non-Current Liabilities (2010 - 2026)

Updated

Pacira BioSciences' Total Non-Current Liabilities was $545.35 million in Q2 2026, down 27.7% from $754.34 million a year earlier but up 2.9% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Pacira BioSciences came in at $551.23 million, down 27.3% from FY2024.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $758.35 million in FY2024 (+9.8%), $690.68 million in FY2023 (-23.0%), $896.52 million in FY2022 (-32.3%) and $1.32 billion in FY2021 (+103.5%).
  • Quarterly Total Non-Current Liabilities has moved between $530.03 million (Q1 2026) and $1.32 billion (Q4 2021) over five years.
  • Compared with a year earlier, Total Non-Current Liabilities has declined for four straight quarters, with an average decline of 10.2% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q4 2021 (growth of 103.5%); the worst was Q1 2023 (a decline of 36.5%).
  • Per Business Quant data, PCRX's Total Non-Current Liabilities in the three quarters before Q2 2026 was $530.03 million (Q1 2026), $551.23 million (Q4 2025) and $545.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Pacira BioSciences 997.55 Mn 59.58 Mn 148.24 Mn 545.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 545.35 Mn
Mar 31, 2026 530.03 Mn
Dec 31, 2025 551.23 Mn
Sep 30, 2025 545.06 Mn
Jun 30, 2025 754.34 Mn
Mar 31, 2025 764.26 Mn
Dec 31, 2024 758.35 Mn
Sep 30, 2024 759.32 Mn
Jun 30, 2024 754.54 Mn
Mar 31, 2024 678.47 Mn
Dec 31, 2023 690.68 Mn
Sep 30, 2023 690.97 Mn
Jun 30, 2023 722.62 Mn
Mar 31, 2023 743.80 Mn
Dec 31, 2022 896.52 Mn
Sep 30, 2022 945.13 Mn
Jun 30, 2022 957.88 Mn
Mar 31, 2022 1.17 Bn
Dec 31, 2021 1.32 Bn
Sep 30, 2021 629.85 Mn
API Access

Pacira BioSciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PCRX&period=max&api_key=YOUR_API_KEY